Affiliation:
1. Department of Anesthesiology, Stony Brook University Hospital, Stony Brook, NY 11794, USA
Abstract
Lower back pain (LBP) is a widely prevalent global health issue, affecting over half a billion people and remaining the leading cause of years lived with disability (YLDs). LBP significantly impacts healthcare systems, with substantial costs related to surgical procedures and lost workdays. Vertebrogenic back pain (VBP), characterized by specific clinical symptoms and associated with Modic changes (MC) in vertebral endplates, best seen on MRI, is a significant subset of LBP. This paper explores the pathophysiology, diagnosis, and current reports and studies focusing on VBP and the role of basivertebral nerve (BVN) ablation as a therapeutic intervention. Multiple studies, including randomized controlled trials (RCTs) and meta-analyses, demonstrate the efficacy of BVN ablation in reducing pain and improving function in patients with chronic LBP associated with MC.
Reference29 articles.
1. Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021;Ferreira;Lancet Rheumatol.,2023
2. GBD 2019 Risk Factors Collaborators (2020). Global burden of 87 risk factors in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1223–1249.
3. The epidemiology of low back pain in primary care;Kent;Chiropr. Osteopat.,2005
4. Developments in Minimally Invasive Surgical Options for Vertebral Pain: Basivertebral Nerve Ablation—A Narrative Review;Sherwood;J. Pain. Res.,2021
5. Pain Location and Exacerbating Activities Associated with Treatment Success following Basivertebral Nerve Ablation: An Aggregated Cohort Study of Multicenter Prospective Clinical Trial Data;McCormick;Pain. Med.,2022